NIH: Immune Drivers of Autoimmune Disease (IDAD) (U01 Clinical Trial Not Allowed)RFA-AI-22-012
Sponsor: NIHInternal Deadline: 05/06/2022Institutional Submission Limit: 1Sponsor Deadline: 07/01/2022Program WebsiteNIH: Immune Drivers of Autoimmune Disease (IDAD) (U01 Clinical Trial Not Allowed)RFA-AI-22-012
This Funding Opportunity Announcement (FOA) invites applications to participate in the Immune Drivers of Autoimmune Disease (IDAD) cooperative research program, which will focus on defining the immunologic states and dynamics that drive autoimmune disease. The main objective of this program is to enhance our understanding of the immunologic processes, events, and changes that underlie the clinical manifestations of autoimmune diseases, including disease flare, remission, and progression of established disease, as well as the progression from a state of elevated risk to clinical diagnosis of autoimmune disease.
U of SC may submit only one application in response to this solicitation.
Your application submission MUST be coordinated with the Office of the Vice President for Research. Please send an updated NIH formatted biosketch (https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-073.html) and a two page abstract via email to Richard White (firstname.lastname@example.org) by May 6, 2022.
NIH indicates that a letter of intent IS NOT REQUIRED and a full application is due by July 1, 2022 .
For more information: https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-22-012.html#_3._Additional_Information